Abstract:Yongwei Gu, 1– 3, * Qing Gu, 4, * Qing Yang, 1, 2 Meng Yang, 3 Shengzhang Wang, 5 Jiyong Liu 1– 3 1 Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China; 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China; 3 Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China; 4 Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai 200070, People's Republic of China; 5 Institute of Biomechanics, Department of Aeronautics and Astronautics, Fudan University, Shanghai 200433, People's Republic of China *These authors contributed equally to this work Correspondence: Shengzhang Wang Department of Aeronautics and Astronautics, Institute of Biomechanics, Fudan University, Shanghai 200433, People's Republic of China Tel/Fax +86-21-65647825 Email szwang@fudan.edu.cn Jiyong Liu Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China Tel/Fax +86-21-64175590 Email liujiyong@fudan.edu.cn Background: Skin pharmacokinetics is an indispensable indication for studying the drug fate after administration of transdermal drug delivery systems (TDDS). However, the heterogeneity and complex skin structured with stratum corneum, viable epidermis, dermis, and subcutaneous tissue inevitably leads the drug diffusion coefficient ( K p) to vary depending on the skin depth, which seriously limits the development of TDDS pharmacokinetics in full thickness skin. Methods: A multilayer geometry skin model was established and the K p of drug in SC, viable epidermis, and dermis was obtained using the technologies of molecular dynamics simulation, in vitro permeation experiments, and in vivo microdialysis, respectively. Besides, finite element analysis (FEA) based on drug K ps in different skin layers was applied to simulate the paeonol nanoemulsion (PAE-NEs) percutaneous dynamic penetration process in two and three dimensions. In addition, PAE-NEs skin pharmacokinetics profile obtained by the simulation was verified by in vivo experiment. Results: Coarse-grained modeling of molecular dynamic simulation was successfully established and the K p of PAE in SC was 2.00× 10 − 6 cm 2 /h. The K p of PAE-NE in viable epidermis and in dermis detected using penetration test and microdialysis probe technology, was 1.58× 10 − 5 cm 2 /h and 3.20× 10 − 5 cm 2 /h, respectively. In addition, the results of verification indicated that PAE-NEs skin pharmacokinetics profile obtained by the simulation was consistent with that by in vivo experiment. Discussion: This study demonstrated that the FEA combined with the established multilayer geometry skin model could accurately predict the skin pharmacokinetics of TDDS. Keywords: nano transdermal drug delivery system, skin pharmacokinetics, finite element analysis, multilayer geometry model, diffusion coefficient, paeonol nanoemulsion

Finite Element Analysis for Predicting Skin Pharmacokinetics of Nano Transdermal Drug Delivery System Based on the Multilayer Geometry Model

Penetration profile and human cadaver skin distribution of finasteride from vesicular nanocarriers.

In Silico Prediction of Percutaneous Absorption and Disposition Kinetics of Chemicals

Numerical simulation of transdermal delivery of drug nanocarriers using solid microneedles and medicated adhesive patch

Pharmacokinetic Study of Triptolide Nanocarrier in Transdermal Drug Delivery System—Combination of Experiment and Mathematical Modeling

A skin pharmacokinetics study of permeation enhancers: The root cause of dynamic enhancement effect on in vivo drug permeation

Modeling Transdermal Permeation. Part 2. Predicting the Dermatopharmacokinetics of Percutaneous Solute

PREDICTING SKIN PERMEABILITY OF DRUGS WITH THEORETICAL PARAMETERS

New trends in mechanistic transdermal drug delivery modelling: Towards an accurate description of skin microstructure

Multi‐phase Multi‐Layer Mechanistic Dermal Absorption (MPML MechDermA) Model to predict local and systemic exposure of drug products applied on skin

Development of a Two-Dimensional Model for Predicting Transdermal Permeation with the Follicular Pathway: Demonstration with a Caffeine Study

Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays

A two-phase two-layer model for transdermal drug delivery and percutaneous absorption

Size-Dependent Absorption Through Stratum Corneum by Drug-Loaded Liposomes

Amphiphilic poly{[alpha-maleic anhydride-omega-methoxy-poly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery.

Finite dose skin mass balance including the lateral part: comparison between experiment, pharmacokinetic modeling and diffusion models

Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy

Relating transdermal delivery plasma pharmacokinetics with in vitro permeation test (IVPT) findings using diffusion and compartment-in-series models

Lateral Dermal Penetration Is Dependent on the Lipophilicity of Active Ingredients

The Finite Element Analysis Research on Microneedle Design Strategy and Transdermal Drug Delivery System

Assessing the Potential for Drug-Nanoparticle Surface Interactions To Improve Drug Penetration into the Skin